source
- ARPA-H teams meet FDA within two months of launching autonomous clinical AI programMultiple teams in ARPA-H's Advocate program, which focuses on autonomous clinical AI tools, have already held an initial informational meeting with the FDA. The meeting took place less than two mo…
- Trump's MFN drug pricing agreements complicate new drug launchesPresident Donald Trump announced nine new agreements with drug manufacturers on Aug. 31, extending the “most favored nation” (MFN) pricing framework. Under MFN, U.S. prices for participating drugs…